Browse our anti-PTAFR (PTAFR) Antibodies

Full name:
anti-Platelet-Activating Factor Receptor Antibodies (PTAFR)
On are 42 Platelet-Activating Factor Receptor (PTAFR) Antibodies from 11 different suppliers available. Additionally we are shipping PTAFR Kits (18) and PTAFR Proteins (3) and many more products for this protein. A total of 66 PTAFR products are currently listed.
MGC52896, MGC160177, PAF-R, PAFr
list all antibodies Gene Name GeneID UniProt
PTAFR 5724 P25105
PTAFR 19204 Q62035
PTAFR 58949 P46002

Show all species

Show all synonyms

Most Popular Reactivities for anti-PTAFR (PTAFR) Antibodies

Select your species and application

anti-Human PTAFR Antibodies:

anti-Mouse (Murine) PTAFR Antibodies:

anti-Rat (Rattus) PTAFR Antibodies:

All available anti-PTAFR Antibodies

Go to our pre-filtered search.

Top referenced anti-PTAFR Antibodies

  1. Human Polyclonal PTAFR Primary Antibody for IF (p), IHC (p) - ABIN687127 : Hammond, Lu, Gelbard: Platelet Activating Factor Enhances Synaptic Vesicle Exocytosis Via PKC, Elevated Intracellular Calcium, and Modulation of Synapsin 1 Dynamics and Phosphorylation. in Frontiers in cellular neuroscience 2016 (PubMed)

More Antibodies against PTAFR Interaction Partners

Human Platelet-Activating Factor Receptor (PTAFR) interaction partners

  1. PAFR overexpression is associated with pneumococcal infection.

  2. WEB-2086 represents an innovative class of candidate drugs for inhibiting PAFr-dependent lung infections caused by the main bacterial drivers of smoking-related COPD (show ARCN1 Antibodies).

  3. PAF (show KIAA0101 Antibodies) stimulation dose-dependently promoted the invasion, migration and growth of prostate cancer cells in vitro, while knockdow our findings demonstrate that PAFR can activate ERK1/2 (show MAPK1/3 Antibodies) pathway, and subsequently increase MMP-3 (show MMP3 Antibodies) expression and decrease E-cadherin (show CDH1 Antibodies) expression

  4. PAFR is overexpressed in NSCLC as well as in breast, colorectal, and gastric carcinomas. PAFR expression correlates with clinical stages, survival time, and distant metastasis. PAF (show KIAA0101 Antibodies)/PAFR signaling also upregulated IL6 (show IL6 Antibodies) expression and STAT3 (show STAT3 Antibodies) activation.

  5. we made the first demonstration that dysregulation of PAFR and the positive regulatory loop between PAFR and pAKT (show AKT1 Antibodies) contribute to malignant progression of esophageal squamous cell carcinoma

  6. Data support an important role for PAFR in tumor growth and suggest that engagement of PAFR interferes with selected pathways in macrophages, changing their phenotype into that of a regulatory with suppressor activities. [review]

  7. Epithelial PAFr expression is upregulated in smokers, especially in those with COPD (show ARCN1 Antibodies), and is not obviously affected by inhaled corticosteroid therapy.

  8. Results suggest that WEB2086 and AG1478 are synergistic in ovarian cancer cells with high expression of both platelet-activating factor receptor (PAFR) and epidermal growth factor receptor (EGFR (show EGFR Antibodies)).

  9. PAFR may have an important role in modulating the cisplatin sensitivity of ovarian cancer cells.

  10. patients presenting elevated PAFR expression had significantly longer survival times compared to those with low PAFR expression (log-rank test, p<0.001).

Mouse (Murine) Platelet-Activating Factor Receptor (PTAFR) interaction partners

  1. Study demonstrated that PAFR has a compelling involvement in Brucella abortus uptake as a promoter of phagocytosis, which is associated with JAK2 (show JAK2 Antibodies) signaling activation.

  2. In the absence of PAFR signalling, monocytes and macrophages acquire a pro-inflammatory phenotype, resulting in adipose tissue inflammation and metabolic dysfunction.

  3. Data (including data from studies in knockout mice) suggest that signal transduction via platelet-activating factor (PAF (show KIAA0101 Antibodies)) and PAF receptor is involved in regulation of lipid metabolism/inflammation in liver of mice on high-refined carbohydrate diet.

  4. ExoU activates NF-kappaB (show NFKB1 Antibodies) by PAFR signalling, which in turns enhances PAFR expression, highlighting an important mechanism of amplification of response to this P. aeruginosa toxin.

  5. In PAF receptor-knockout mice, diet-induced obesity is exacerbated.

  6. Bacteria did not associate with PAFR, indicating an indirect role of PAFR in pneumococcal adhesion to endothelial cells.

  7. PAFR deficiency resulted in less inflammation in adipose tissue and improvement in glucose homeostasis in mice fed a high-carbohydrate diet

  8. PAFR and CD36 (show CD36 Antibodies) coimmunoprecipitated with flotillin-1 (show FLOT1 Antibodies), a constitutive lipid raft protein, and disruption of these membrane microdomains by methyl-beta-cyclodextrin reduced apoptotic cells phagocytosis

  9. Our findings establish the existence of a functional partnership PAF-R/eNOS (show NOS3 Antibodies) on endothelial cell plasma membrane.

  10. Activation of PAF-receptor induces regulatory dendritic cells through PGE2 and IL-10 (show IL10 Antibodies).

Rabbit Platelet-Activating Factor Receptor (PTAFR) interaction partners

  1. The gene expression of PAFR was upregulated, as an effect of light exposure, in the third eyelid but not in the cornea.

Cow (Bovine) Platelet-Activating Factor Receptor (PTAFR) interaction partners

  1. PAF (show KIAA0101 Antibodies) and luteinizing hormone signaling plays an important role in regulating the production of excessive oxidants.

  2. The results provide clear evidence for expression of PAFr in bovine granulosa cells and its functional involvement in PAF (show KIAA0101 Antibodies)/PAFr-mediated stimulation of cell recruitment.

PTAFR Antigen Profile

Antigen Summary

This gene encodes a seven-transmembrane G-protein-coupled receptor for platelet-activating factor (PAF) that localizes to lipid rafts and/or caveolae in the cell membrane. PAF (1-0-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine) is a phospholipid that plays a significant role in oncogenic transformation, tumor growth, angiogenesis, metastasis, and pro-inflammatory processes. Binding of PAF to the PAF-receptor (PAFR) stimulates numerous signal transduction pathways including phospholipase C, D, A2, mitogen-activated protein kinases (MAPKs), and the phosphatidylinositol-calcium second messenger system. Following PAFR activation, cells become rapidly desensitized and this refractory state is dependent on PAFR phosphorylation, internalization, and down-regulation. Alternative splicing results in multiple transcript variants.

Alternative names and synonyms associated with PTAFR

  • platelet-activating factor receptor (ptafr) antibody
  • platelet-activating factor receptor (PTAFR) antibody
  • platelet-activating factor receptor (Ptafr) antibody
  • platelet-activating factor receptor (LOC100354046) antibody
  • platelet-activating factor receptor-like (LOC100523973) antibody
  • MGC52896 antibody
  • MGC160177 antibody
  • PAF-R antibody
  • PAFr antibody

Protein level used designations for PTAFR

platelet-activating factor receptor , PAF-R , PAF receptor , PAFr

379327 Xenopus laevis
443041 Ovis aries
469249 Pan troglodytes
493365 Xenopus (Silurana) tropicalis
100590550 Nomascus leucogenys
5724 Homo sapiens
19204 Mus musculus
58949 Rattus norvegicus
100354046 Oryctolagus cuniculus
100720710 Cavia porcellus
487336 Canis lupus familiaris
518283 Bos taurus
100860976 Capra hircus
428209 Gallus gallus
101104560 Ovis aries
716788 Macaca mulatta
100523973 Sus scrofa
Selected quality suppliers for anti-PTAFR (PTAFR) Antibodies
Did you look for something else?